Drug class
Bronchodilator Agents clinical trials
A class of medicines: the studies that test any of its 38 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the bronchodilator agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Fluticasone-Salmeterol Drug Combination
- 26
- Isospaglumic acid
- 2
- Tulobuterol
- 2
- Hyoscyamine
- 2
- Mometasone Furoate, Formoterol Fumarate Drug Combination
- 2
- Racepinephrine
- 2
- Metaproterenol
- 1
- Dimephosphon
- 1
Studies by the year they started
1,980 studies that test it; most in 2007 (105); 1 more planned to start later
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1992 | 1 |
| 1993 | 1 |
| 1995 | 1 |
| 1996 | 2 |
| 1997 | 1 |
| 1998 | 11 |
| 1999 | 13 |
| 2000 | 14 |
| 2001 | 16 |
| 2002 | 47 |
| 2003 | 36 |
| 2004 | 62 |
| 2005 | 73 |
| 2006 | 82 |
| 2007 | 105 |
| 2008 | 99 |
| 2009 | 86 |
| 2010 | 93 |
| 2011 | 92 |
| 2012 | 97 |
| 2013 | 97 |
| 2014 | 83 |
| 2015 | 80 |
| 2016 | 100 |
| 2017 | 82 |
| 2018 | 76 |
| 2019 | 77 |
| 2020 | 57 |
| 2021 | 66 |
| 2022 | 71 |
| 2023 | 88 |
| 2024 | 70 |
| 2025 | 45 |
| 2026 | 55 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 845 · Other 1,154
GlaxoSmithKline (167) · Boehringer Ingelheim (129) · AstraZeneca (80) · Teva Branded Pharmaceutical Products R&D, Inc. (24) · Respirent Pharmaceuticals Co Ltd. (18) · Dey (17) · Dr. Falk Pharma GmbH (16) · Danish Headache Center (15)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 1,999
- Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)Not yet recruitingPhase 3Eurofarma Laboratorios S.A.NCT06234345Written as Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg
- Cilostazol for Prevention of Recurrent Stroke TrialNot yet recruitingPhase 3Stanford UniversityNCT07174414Written as Cilostazol 100 mg Tablets
- A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia ControlRecruitingPhase 3Jaeb Center for Health ResearchNCT07095894Written as Atropine
- Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationRecruitingNot applicableChina National Center for Cardiovascular DiseasesNCT07877519Written as Salbutamol
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingPhase 2Fudan UniversityNCT05076682Written as Theophylline
- Ventilation and Perfusion in AsthmaticsRecruitingPhase 4University of MiamiNCT07426458Written as Albuterol Sulfate
- ESP Blocks in Breast Free FlapsRecruitingPhase 1Carilion ClinicNCT07891039Written as Bupivacaine with Epinephrine and Dexamethasone
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03109288Written as Cilostazol
- Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)Not yet recruitingPhase 4University of Tennessee Graduate School of MedicineNCT07721922Written as formoterol fumarate
- Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageRecruitingPhase 3Beijing Tiantan HospitalNCT07249853Written as Cilostazol 100 mg BID
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingPhase 3Novartis PharmaceuticalsNCT05776927Written as Salmeterol Xinafoate / Fluticasone Propionate
- Low-Dose Atropine Eye Drops for Excessive Tearing (Epiphora)RecruitingPhase 2Rehan AhmedNCT07816224Written as Atropine sulfate ophthalmic solution 0.005%
- Comparison of Milrinone and Epinephrine on TAPSERecruitingNot applicableMansoura UniversityNCT07144267Written as Epinephrine
- Early Intervention for High Risk Premyopic ChildrenNot yet recruitingPhase 2National Yang Ming Chiao Tung University HospitalNCT07863713Written as 0.025% atropine eye drops
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingPhase 3AstraZenecaNCT06283966Written as BGF MDI 320/14.4/9.6 μg
- Epinephrine Dose: Optimal Versus Standard Evaluation TrialRecruitingPhase 4Unity Health TorontoNCT03826524Written as Epinephrine
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruitingPhase 3GlaxoSmithKlineNCT05757102Written as FF/UMEC/VI
- Little Lungs StudyNot yet recruitingPhase 1/2University of Wisconsin, MadisonNCT06855043Written as Budesonide
- Control of Myopia in Young Children Using H.O.P.E. Lenses Combined With 0.02% Atropine Eye DropsNot yet recruitingNot applicableRuihua WeiNCT07846787Written as 0.02% Atropine Sulfate Eye Drops
- Novel Method for Removal of Orally Deposited Inhaled Fluticasone PropionateNot yet recruitingPhase 4University of Wisconsin, MadisonNCT07664527Written as Fluticasone Propionate
See all 1,999 studies that test one of the bronchodilator agents →
Codes
What other systems call Bronchodilator Agents · ClinicalTrials.gg INT007093
- MeSH (NLM) D001993Bronchodilator AgentsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001993 | Bronchodilator Agents | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.